Table V.
Enriched KEGG pathways for the differentially-expressed genes in the module.
| Term | Description | Gene number | Gene symbol | P-value |
|---|---|---|---|---|
| 4010 | MAPK signaling pathway | 14 | GADD45G, MAP2K3, HSPA2, AKT2, HSPA1A, FOS, HSPA1B, PDGFA, DUSP10, DUSP1, GNA12, TAOK1, HSPA6, TGFB3 | 2.91×10−9 |
| 5200 | Pathways in cancer | 10 | BCL2, DVL1, CDKN1A, AKT2, FOS, PML, PDGFA, VHL, TCF7, TGFB3 | 9.01×10−5 |
| 5145 | Toxoplasmosis | 9 | BCL2, MAP2K3, HSPA2, AKT2, HSPA1A, SOCS1, HSPA1B, HSPA6, TGFB3 | 3.30×10−7 |
| 4141 | Protein processing in endoplasmic reticulum | 7 | BCL2, DNAJB1, HSPA2, HSPA1A, HSPA1B, HSPBP1, HSPA6 | 1.68×10−4 |
| 5215 | Prostate cancer | 6 | BCL2, CDKN1A, AKT2, PDGFA, TCF7, PDPK1 | 3.98×10−5 |
| 4144 | Endocytosis | 6 | HSPA2, HSPA1A, HSPA1B, PML, HSPA6, TGFB3 | 3.17×10−3 |
| 5210 | Colorectal cancer | 5 | BCL2, AKT2, FOS, TCF7, TGFB3 | 7.89×10−5 |
| 4910 | Insulin signaling pathway | 5 | AKT2, SOCS1, EIF4EBP1, PPP1R3C, PDPK1 | 3.14×10−3 |
| 5221 | Acute myeloid leukemia | 4 | AKT2, PML, EIF4EBP1, TCF7 | 7.44×10−4 |
| 4612 | Antigen processing and presentation | 4 | HSPA2, HSPA1A, HSPA1B, HSPA6 | 2.18×10−3 |
KEGG, Kyoto Encyclopedia of Genes and Genomes; MAPK, mitogen-activated protein kinases.